| Literature DB >> 31253612 |
Morten Sall Jensen1,2, Kim Rose Olsen3, Lars Morsø1,4, Jens Søndergaard5, Berit Schiøttz-Christensen1,6.
Abstract
OBJECTIVES: This study reports lumbar MRI referral patterns in the Region of Southern Denmark (RSD) and investigates the hypothesis that we will see an increase in imaging rates (MRI rates) following new referral options to lumbar MRI in the RSD in comparison with the other regions in Denmark from 2010 to 2013.Entities:
Keywords: MRI; low back pain; magnetic resonance imaging; organisation of health services; public health
Mesh:
Year: 2019 PMID: 31253612 PMCID: PMC6609080 DOI: 10.1136/bmjopen-2018-025921
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Figure 1Changes in the referral patterns to lumbar MRI in Region of Southern Denmark from 2008 to 2013 using a 100% stacked curve diagram. GP, general practitioners.
Differences in proportions of patients enlisted at a GP from either intervention or control regions for preintervention years (2008 and 2009 combined)
| RSD’s GPs (n=832) | Control regions’ GPs (n=1878)† | t-test‡ | |||
| Mean | SD | Mean | SD | ||
| Comorbidity score 2+ | 0.031 | 0.008 | 0.031 | 0.010 | * |
| Full time job | 0.565 | 0.060 | 0.570 | 0.064 | * |
| Vocational education | 0.443 | 0.029 | 0.450 | 0.038 | * |
| Marital status single | 0.318 | 0.064 | 0.323 | 0.076 | * |
| Income DKK 0–399.999 | 0.899 | 0.028 | 0.888 | 0.039 | * |
| Gender (women) | 0.509 | 0.063 | 0.509 | 0.066 | |
| 18–59 year of age | 0.674 | 0.076 | 0.679 | 0.082 | |
| GPs’ id list size | 2265.060 | 3197.228 | 2212.976 | 3440.372 | |
| Visits to physiotherapist | 0.086 | 0.022 | 0.096 | 0.026 | * |
| Visits to chiropractor | 0.079 | 0.024 | 0.072 | 0.023 | * |
| Visits to office-based specialists | 0.035 | 0.022 | 0.037 | 0.027 | * |
| Use of pain medication | 0.153 | 0.037 | 0.150 | 0.040 | |
Means reflect proportions of patients divided by the GP list size.
†Including GPs from the Zealand Region, the Central Denmark Region and the North Denmark Region.
‡The t-test by group with unequal variance.
*P<0.05.
GP, general practitioner; N, number of observations; RSD, Region of Southern Denmark.
Figure 2Lumbar MRI rates for RSD and the control regions from 2008 to 2013. GP, general practitioner; RSD, Region of Southern Denmark, Control (the Zealand Region, the Central Denmark Region and the North Denmark Region).
DD and PSM estimates from unadjusted and adjusted models with RSD and the control regions
| Lumbar MRI rates | ||||
| DD | PSM† | |||
| Unadjusted | Adjusted model‡ | Quarterly data§ | ||
| DD (RSD* post-treatment years | 1.83* (1.37 to 2.29) | 1.39* (0.93 to 1.85) | 0.43* (0.32 to 0.53) | 3.80* (2.67 to 4.94) |
| Constant | 9.04* (8.85 to 9.23) | 2.60 (−5.28 to 10.48) | 2.24* | – |
Four models showing the main outcome lumbar MRIs per 1000 enlisted with a GP.
†The PSM model use conventional options; nearest neighbour with (calliper = one-fourth of the SD on the propensity scores). We use the MRI rates in 2008 and 2009 as matching covariates to control for unobservable selection.31 32 Furthermore, we control for clustering at GP level.34
‡Adjusted model include covariates for comorbidity score 2+, full time job, vocational education, marital status single, income DKK 0–399.999, male, 18–59 years of age, visit at physiotherapist, visits at chiropractor, visits at office-based spine specialist, use of pain medication.
§The DD model with quarterly data use the same covariates. However, in addition, we included quarter dummies (Q1, Q2 Q3 and Q4) to take away the obvious seasonality shown in the online supplementary figure A1.
*P<0.001.
DD, difference in difference; GP, general practitioner; PSM, propensity score matching; RSD, Region of Southern Denmark.
Figure 3Dynamic year effects using the adjusted model, with multiple difference in difference estimates with 2009 as the preintervention period and all postintervention years for Region of Southern Denmark and the control regions. b, beta estimates from the difference in difference analysis; min95, lower bound of the 95% CI of the beta estimate; max95, upper bound of the 95% CI of the beta estimate.